Our study participants offer hope for many people and an opportunity to help researchers find new and better treatments.
Our people are passionate about clinical research and advancing the future of medicine. PRA manages an average of 150 studies per year around the world at our various clinical research sites.
We have an experienced team of physicians, clinic and support staff dedicated to making our participants' experience as positive and comfortable as possible. Participant safety is our top priority at all times.
Located outside of Philadelphia, our 60-bed facility is managed by an experienced team of doctors, psychiatrists, nurses, and medical research professionals. We take pride in providing an inviting atmosphere for our participants while they are on site. All of our participants enjoy delicious meals prepared by a renowned local caterer and comfortable private and semi-private bedrooms which are equipped with cable television. During downtime, participants can relax in our spacious recreation area, which also includes a library of books, an assortment of board games, a video game system, and a theatre-like setting. Complimentary WiFi is offered for those patients who would like to connect to their own electronics. We also provide an on-site laundry facility.
Psychiatric and neurological disorders
- Alzheimer’s disease
- Mild cognitive impairment (MCI)
- Parkinson’s disease
- Post-partum depression
- Attention deficit disorder (ADD)
- Attention deficit hyperactivity disorder (ADHD)
- Bipolar disorder
- Tourette’s syndrome
- Infectious disease
- Pediatric trials
David G. Krefetz, DO, MBA is board certified in Psychiatry and Child and Adolescent Psychiatry. He is also a Certified Physician Investigator. He has over 30 years of experience providing medical care in clinical and psychiatric research. He has been with the PRA site since 2004 and has conducted over 250 clinical trials.
Sarah Kazmi is the Director of Clinical Research Services at Marlton, NJ. Sarah holds a Doctorate in Medicine and comes to PRA with almost 10 years of research experience in Phase I-IV clinical trials. Some of her previous work has been in indications such as Respiratory, Stroke, Diabetes and CNS. She has been with PRA since April 2015.
In most cases, you can have visitors during approved visiting hours. Visitors must bring an ID.
Depending on the study you participate in, you may have to wait 30 or more days to enroll again.
Each study will have different requirements for the visits. Some may be as short as 30 minutes and some may be extended in house stays.
Yes, we provide door to door transportation to help get you to your study visits and back home safely.
Smoking is generally allowed, but some studies may have restrictions. You will learn about these restrictions during the screening visit.